Florida Access Score: 47.7/100
Composite of methadone OTP density, buprenorphine provider density, mental health shortage need-met %, Medicaid coverage breadth, 1115 SUD waiver status, and legal protections. How we score.
Florida has 70 currently SAMHSA-certified opioid treatment programs across 49 cities. Methadone is dispensed daily on-site at OTPs, which is the regulatory boundary that defines this list.
Composite analysis
Florida ranks in the upper half of states for treatment access pressure. Some counties carry materially worse access than the state-level number suggests.
TAPI is a CCIWA composite. Each input is z-scored across 50 states plus DC and Puerto Rico, then combined as a weighted sum (HPSA 30%, frequent mental distress 25%, unemployment 15%, treatment density 30%, sign-flipped). The result is rescaled 0 to 100 by percentile rank. Read the full methodology.
Composite of methadone OTP density, buprenorphine provider density, mental health shortage need-met %, Medicaid coverage breadth, 1115 SUD waiver status, and legal protections. How we score.
| Component | Detail | Points |
|---|---|---|
| OTP density | 0.31 OTPs per 100K residents | 9.3 / 30 |
| Buprenorphine density | 8.31 providers per 100K | 6.6 / 20 |
| Mental health HPSA need met | 23.15% | 7.7 / 20 |
| Medicaid breadth | 5 of 5 service categories covered | 15 / 15 |
| 1115 SUD waiver | None | 4 / 10 |
| Legal protections | Good Samaritan: Yes · Naloxone access: Yes | 5 / 5 |
| Service | Covered | Notes |
|---|---|---|
| Methadone | Yes | Prior auth required |
| Buprenorphine | Yes | |
| Naltrexone (Vivitrol) | Yes | |
| Outpatient SUD | Yes | |
| Residential SUD | Yes |
1115 SUD waiver: Pending (as of Jan 2026). IMD exclusion waived. Expires MMA: 2030-06-30 (does not include IMD SUD); Pending IMD SUD application has no approval date.